MOL — Molecule Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Molecule, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.023 | -0.075 | -0.025 | -1.22 |
| Non-Cash Items | -0 | 0 | 0 | -0.04 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.004 | 0.004 | -0 | -0.128 |
| Change in Accounts Receivable | ||||
| Change in Accounts Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.027 | -0.071 | -0.025 | -1.39 |
| Capital Expenditures | — | — | — | -0.003 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | — | 0.077 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | — | — | 0.074 |
| Financing Cash Flow Items | 0 | -0 | -0 | -1.17 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.09 | 0.018 | 0.015 | 10.9 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.063 | -0.053 | -0.01 | 9.55 |